---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-051395"
form_type: "8-K"
ticker: "ANSC"
cik: "0001854149"
company_name: "Agriculture & Natural Solutions Acquisition Corp"
filed_at: "2024-05-01T23:59:59+00:00"
generated_at: "2026-06-03T03:15:15.544526+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# ANSC non-compliant with Nasdaq audit-committee rule after Aaker resignation; cure period granted

## Summary
- Nasdaq confirmed non-compliance with Rule 5605(c)(2) after Dr. Jennifer Aaker resigned from Audit Committee on March 26.
- Cure period: until earlier of next annual meeting or March 26, 2025; if meeting held before Sept 23, 2024, then due Sept 23, 2024.
- No immediate effect on listing; securities continue trading under ANSCU, ANSC, ANSCW.
- Company intends to appoint an additional independent director before cure period ends; no guarantee of compliance.

## SEC filing metadata
- accession: 0000950170-24-051395
- form_type: 8-K
- ticker: ANSC
- cik: 0001854149
- company_name: Agriculture & Natural Solutions Acquisition Corp
- filed_at: 2024-05-01T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1854149/000095017024051395/0000950170-24-051395-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1854149/000095017024051395/ansc-20240430.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-051395
- JSON: https://secwatch.observer/filing/0000950170-24-051395.json
- Plain text: https://secwatch.observer/filing/0000950170-24-051395.txt

## Key facts
- Listing & Compliance Notices
  Agriculture & Natural Solutions Acquisition Corp received a nasdaq deficiency notice notice regarding audit committee (rules 5605(c)(2), 5605(c)(4)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: audit committee
  - Rules: 5605(c)(2), 5605(c)(4)
  source text: April 30, 2024, the Company received a letter from Nasdaq confirming such non-compliance and confirming that, in accordance with Nasdaq Rule 5605(c)(4), Nasdaq will provide the Company a cure period in order to regain compliance as follows: • Until the earlier of the Company’s next annual shareholders’ meeting or March 26, 2025; or • If the next annual shareholders’ meeting is held before September 23, 2024, then the Company must evidence compliance no later than September 23, 2024. The foregoing has no immediate effect on the Company’s Nasdaq listing and its securities will continue to be lis
  evidence_url: https://www.sec.gov/Archives/edgar/data/1854149/000095017024051395/0000950170-24-051395-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.